These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
    Author: Molica S, Vacca A, Tucc L, Ribatti D.
    Journal: Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392.
    Abstract:
    We evaluated bone marrow (BM) angiogenesis in 12 responding patients with Binet stage B chronic lymphocytic leukemia who received either chlorambucil or fludarabine. Microvessel density (MVD) was compared between pre-treatment marrow samples and those obtained after at least 4 cycles of chemotherapy. BM angiogenesis decreases in all patients but one, although subset analysis revealed the decrease of BM angiogenesis was significant only in patients who received fludarabine. Even if based on a small number of patients, these results point out the potential in vivo anti-angiogenic activity of fludarabine.
    [Abstract] [Full Text] [Related] [New Search]